Class 3. Pulmonary Hypertension Associated with Lung Disease

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism

Sehua Qu, Lianqiang Shan, Xin Chen, Zhen Zhang, Yumeng Wu, Yun Chen, Feixiang Zhuo, Yitong Wang, Huaifu DongThe First Affiliated Hospital of Bengbu Medical College. China BioMed Central Pulmonary MedicineBMC Pulm Med 2023; 23: DOI: 10.1186/s12890-023-02498-1 AbstractBackground: This study aimed to determine whether postnatal treatment with recombinant human IGF-1 (rhIGF-1)/binding peptide 3 (BP3) ameliorates lung injury and […]

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism Read More »

Evaluation of Postnatal Complications in Clinical and Histological Chorioamnionitis in Extremely Preterm Infants: A Japanese Cohort Study

Shuji Ishida, Hidehiko Nakanishi, Rika Sekiya, Kohei Kawada, Yukako Kosaka, Ayano Yamaguchi, Mari Ooka, On befalf of the Neonatal Research Network of JapanKitasato University.Japan American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/a-2113-4332 AbstractObjective: Terminating pregnancy appropriately before the intrauterine infection has progressed may have an improved prognosis for preterm infants. We evaluate how the combination of histological chorioamnionitis (hCAM) and clinical chorioamnionitis

Evaluation of Postnatal Complications in Clinical and Histological Chorioamnionitis in Extremely Preterm Infants: A Japanese Cohort Study Read More »

Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study

Sophie Breinig, Virginie Ehlinger, Jean-Christophe Roze, Laurent Storme, Heloise Torchin, Xavier Durrmeyer, Gilles Cambonie, Christophe Delacourt, Pierre-Henri Jarreau, Lionel Berthomieu, Olivier Brissaud, Valerie Benhammou, Geraldine Gascoinb, Catherine Arnaud, Pierre-Yves AnceljChildren’s Hospital and Toulouse University. Nantes University Hospital. Lille University Hospital. Assistance Publique-Hôpitaux de Paris. CHI Créteil. Montpellier University Hospital. Necker Children’s Hospital. Bordeaux University Hospital.

Pulmonary hypertension among preterm infants born at 22 through 32 weeks gestation in France: Prevalence, survival, morbidity and management in the EPIPAGE-2 cohort study Read More »

Two-stage learning-based prediction of bronchopulmonary dysplasia in very low birth weight infants: a nationwide cohort study

Jae Kyoon Hwang, Dae Hyun Kim, Jae Yoon Na, Joonhyuk Son, Yoon Ju Oh, Donggoo Jung, Chang-Ryul Kim, Tae Hyun Kim, Hyun-Kyung ParkHanyang University College of Medicine and Hanyang University.Republic of Korea Frontiers in PediatricsFront Pediat 2023; 11DOI: 10.3389/fped.2023.1155921 AbstractIntroduction: The aim of this study is to develop an enhanced machine learning-based prediction models for bronchopulmonary dysplasia

Two-stage learning-based prediction of bronchopulmonary dysplasia in very low birth weight infants: a nationwide cohort study Read More »

Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study

Soumya R. Thomas, Sunil K. Jain, Prashanth Murthy, Chacko J. Joseph, Amuchou Soraisham, Selphee Tang, Aliyah Dosani, Abhay LodhaUniversity of Calgary and Alberta Children’s Hospital. University of Texas Medical Branch. Mount Royal University.Canada and United States American Journal of PerinatologyAm J Perinatol 2023; DOI: 10.1055/a-2121-8878 AbstractObjective: This study aimed to determine neurodevelopmental outcomes of preterm infants born

Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study Read More »

Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia

Csaba Galambos, J. Wells Logan, Pawel Stankiewicz, Przemyslaw Szafranski, Carol Zalles, Jose Gonzales, Sfurti Nath, Shalinkumar Patel, Steven H. AbmanUniversity of Colorado Anschutz School of Medicine. Wolfson Children’s Hospital and the University of Florida College of Medicine. Baylor College of Medicine.United States Pediatric PulmonologyPediatr Pulmonol 2023; DOI: 10.1002/ppul.26571 AbstractWe report the case of a preterm infant

Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia Read More »

Severity of preterm birth and the risk of pulmonary hypertension in childhood: A population-based cohort study in Sweden

Hanna Carr, Anna Gunnerbeck, Peter Eisenlauer, Stefan Johansson, Sven Cnattingius, Jonas F. Ludvigsson, Anna-Karin Edstedt BonamyKarolinska Institutet and Karolinska University Hospital. Södersjukhuset. Örebro University Hospital.Sweden Pediatric and Perinatal EpidemiologyPediatr Perinat Epidemiol 2023; DOI: 10.1111/ppe.12997 AbstractBackground: Preterm birth (<37 completed gestational weeks) has been linked to pulmonary hypertension (PH), but the relationship to severity of preterm birth has

Severity of preterm birth and the risk of pulmonary hypertension in childhood: A population-based cohort study in Sweden Read More »

The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes

Mohamed Ahmed, Nancy G. Casanova, Nahla Zaghloul, Akash Gupta, Marisela Rodriguez, Ian R. Robbins, Carrie L. Kempf, Xiaoguang Sun, Jin H. Song, Vivian Reyes Hernon, Saad Sammani, Sara M. Camp, Alvaro Moreira, Chaur-Dong Hsu, Joe G. N. GarciaUniversity of Arizona Health Sciences. UT Health San Antonio Long School of Medicine. United States Frontiers in PhysiologyFront

The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes Read More »

Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia

Maria V. Fraga, Kevin C. Dysart, Jason Z. Stroller, Matthew Huber, Anysia Fedec, Laura Mercer-Rosa, Haresh KirpalaniThe Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine. Nemours Children’s Health and duPont Hospital for Children. McMaster University.United States and Canada NeonatologyNeonatology 2023; DOI: 10.1159/000531586 AbstractObjectives: Inhaled nitric oxide (iNO) is an effective pulmonary vasodilator. However,

Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia Read More »

Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain

Jason S. Kerstein, Eleonore Valencia, Shane Collins, Alessandra M. Ferraro, David M. Harrild, Kimberlee Gauvreau, Ryan Callahan, Mary P. MullenBoston Children’s Hospital and Harvard Medical School. Children’s Hospital of Philadelphia.United States Pediatric CardiologyPediatr Cardiol 2023; DOI: 10.1007/s00246-023-03233-7 AbstractBackground: Interventional therapies for severe pulmonary arterial hypertension (PAH) can provide right ventricular (RV) decompression and preserve cardiac output. Transcatheter

Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain Read More »

Scroll to Top